Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (tunel)

Journal of Pathology

Volumn 181, Issue 3, 1997, Pages 323-329

  Hellquist, Henrik B ^a   Sundelin, Kaarina ^a   Di Bacco, Alessandra ^b   Tytor, Macie ^a   Manzotti, Michela ^b   Viale, Giuseppe ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; bcl 2; End labelling; Ki 67; Salivary neoplasm; TUNEL

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; SALIVARY GLAND CARCINOMA;

APOPTOSIS; CARCINOMA, ACINAR CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030914632     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K     Document Type: Article

References (32)

1. Seifert G, Batsakis JG, Brocheriou C, et al. Histological typing of salivary gland tumours. WHO International Histological Classification of Tumours. 2nd edn., Berlin: Springer-Verlag, 1991.
2. Seifert G. Histopathology of malignant salivary gland tumours, Eur J Cancer, Oral Oncol 1992; 28B: 49-56.
3. Seifert G, Sobin LH. The World Health Organization's histologic classification of salivary gland tumours. A commentary on the second edition. Cancer 1992; 70: 379-385.
4. Simpson RHW. Classification of tumours of the salivary glands. Hisiopathology 1994; 24: 187-191.
5. Hickman RE, Cawson RA, Duffy SW. The prognosis of specific types of salivary gland tumors. Cancer 1984; 54: 1620-1624.
6. Jensen OJ, Poulsen T, Schiødt. Mucoepidermoid tumors of salivary glands. A long term follow-up study. APMIS 1988; 96: 421-427.
7. Hamper K, Schimmelpenning H, Caselitz J, et al Mucoepidermoid tumors of the salivary glands. Correlation of cytophotometrical data and prognosis. Cancer 1989; 63: 708-717.
8. Hamper K, Caselitz J, Arps H, Askensten U, Auer G, Seifert G. The relationship between nuclear DNA content in salivary gland tumors and prognosis: comparison of mucoepidermoid tumors and acinic cell tumors. Arch Otolaryngol 1989; 246: 328-332.
9. Greiner TC, Robinson RA, Maves MD. Adenoid cystic carcinoma. A clinicopathologic study with flow eyiometric analysis. Am J Clin Pathol 1989; 92: 711-720.
10. Clode AL, Fonseca I, Santos JR, Soares J. Mucoepidermoid carcinoma of the salivary glands: a reappraisal of the influence of tumor differentiation on prognosis. J Surg Oncol 1991; 46: 100-106.
11. Fonseca I, Clode AL, Soares J. Mucoepidermoid carcinoma of major and minor salivary glands. A survey of 43 cases with study of prognostic indicators. Int J Surg Pathol 1993; 1: 3-12.
12. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990; 160: 93-102.
13. Skalova A, Leivo I, von Boguslawsky K, Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol 1994; 173: 13-21.
14. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 1994; 25: 929-935.
15. Wyllie AH. The biology of cell death in tumors. Anticancer Res 1985; 5: 131-136.
16. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 1994; 144: 1045-1057.
17. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-445.
18. Nunez G, London L, Hockenbery D, Alexander M, McKearn J, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
19. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993; 329: 690-694.
20. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, Pierotti MA. BCL-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 1994; 172: 337-342.
21. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareshi M, Viale G. The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 1994; 424: 47-51.
22. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
23. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J Cell Biol 1992; 119: 493-501.
24. Tsujimoto Y, Cossman J, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
25. H on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
26. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Nutl Acad Sci USA 1985; 82: 7439-7443.
27. McDonnell TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52: 6940-6944.
28. Lu Q-L, Elia G, Lucas S, Alero Thomas J. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993; 53: 29-35.
29. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homlog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
30. Miyashita T, Krajewski S, Krajewski M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 1994; 9: 1799-1805.
31. Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279-284.
32. Reed JC. BCL-2 protein function: insights from protein-protein interactions. Proc 2nd Ann Apoptosis Res, Cambridge, MA, 1995.